It is our mission to secure Indiana’s position as a global leader in life sciences by advocating, connecting, promoting, and delivering tangible benefits on behalf of our diverse corporate members.
IHIF members are eligible for discounts and savings on a wide variety of products and services geared towards life sciences companies and general business needs. From lab supplies, waste removal and insurance, to office supplies and credit cards, there is something here for every company. Explore your options and enjoy the benefits of being an IHIF member!
IHIF Warsaw Office Hours - Calling All Companies!

IHIF will hold office hours at the KEDCO office in Warsaw on Thursday, September 8th, 10 am - 2 pm. Do you want to network with other members of Indiana's life sciences ecosystem? Are you concerned about how recent legislation may impact your business? Interested in saving money on key products and services? We'd love to speak with you! CEO Kristin Jones will be available to meet with regional companies and discuss the benefits of membership in IHIF. Contact us to schedule a time!
In Memorium - Representative Jackie Walorski

We mourn the tragic passing of Indiana Rep. Jackie Walorski, Emma Thomson, and Zach Potts. Rep. Walorski was a champion for her district and a fierce advocate for Indiana's medical device industry. She was our Legislator of the Year in 2019, as she was instrumental in the repeal efforts for the medical device tax. Rudy Yakym has been selected to complete her term in Congress.
Return visit planned for October

Our partners at the Scottish LifeSciences Association (SLA) are planning a return visit to Indiana this October 4-14. Led by SLA CEO Scott Johnstone, this fall mission will also include representatives from:
  • Sanondaf  Touchless disinfection services. Exploring US market opportunities. Interested in current hospital/health care disinfection practices, market research, strategic partners, equipment distribution.
  • Benenox – Night time sleep aid.
  • Cellexus - We pioneer revolutionary, market leading single-use airlift bioreactor systems and technology.
  • Intuitive Investments Group (IIG) – IIG seeks to provide investors with exposure to a portfolio of investments concentrating on fast growing and/or high potential life sciences businesses operating predominantly in the UK, continental Europe and the US.
  • Entrust – Your specialist life sciences, healthcare and technology talent partner.

If you would be interested in meeting with any of these companies during their visit, please let us know!
Welcome New IHIF Members and Strategic Partners!
Follow IHIF on Twitter to keep up with all of the latest news, events, and exclusive member benefits!

Featured New Member
Orano Med’s ambition is to develop a new generation of targeted therapies against cancer using the unique properties of lead-212 (212Pb), a rare alpha-emitting radioisotope and one of the more potent therapeutic payloads against cancer cells.

IHIF Member News
As a member benefit, IHIF is pleased to share and highlight member company news! Please send press releases to info@ihif.org or tag us on Twitter @IHIF1.
Need help telling your story?
IHIF is able to provide access to contract/custom press release and writing services. (Fee for service). Inquiries welcome - click here
B2S Life Sciences Launches First-of-its-Kind Critical Reagent Management System
B2S Life Sciences, a start-up company and bioanalytical contract research organization, today announces the official launch of its proprietary Life Cycle Management Plus (LCM+) system. Since 2019, B2S has worked with several global biopharmaceutical companies to design and perfect the platform, a customized inventory management system that provides optimal monitoring of critical reagents.
Learn More (Source: B2S Life Sciences)
Bristol Myers Squibb Completes Acquisition of Turning Point Therapeutics, Expanding Precision Oncology Portfolio
Bristol Myers Squibb (NYSE:BMY) announced today that it has successfully completed its acquisition of Turning Point Therapeutics, Inc. (“Turning Point”), in an all-cash transaction. [...]
“Turning Point has distinguished itself in the field of precision oncology, and this acquisition will further strengthen our leading oncology franchise,” said Elizabeth Mily, Executive Vice President, Strategy & Business Development, Bristol Myers Squibb. “With Turning Point’s lead asset, repotrectinib, Bristol Myers Squibb will be positioned to address a significant unmet medical need for ROS1-positive non-small cell lung cancer patients. We look forward to bringing this promising, innovative medicine to patients in the second half of 2023.”

Learn More (Source BMS)
Other Industry News
AZENTA ANNOUNCES AGREEMENT TO ACQUIRE B MEDICAL SYSTEMS
Azenta, Inc. announced that it has entered into a definitive agreement to acquire B Medical Systems S.á r.l and its subsidiaries (“B Medical”), a market leader in temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments across the globe. The cash purchase price to be paid at closing will be approximately €410 million. Additional cash consideration, up to €50 million, may be paid upon achievement of certain future performance milestones. The transaction is expected to close in October 2022.
Learn More (Source: B Medical Systems)
Ascension St. Vincent Hospital in Indianapolis has earned The Joint Commission’s Gold Seal of Approval and Certification for brain tumor care, making it the first in Indiana to do so. The hospital says it is also now the sixth center in the U.S. to earn brain tumor certification. More (Source: IBJ may require subscription)
MBX Biosciences' investigational treatment for hypoparathyroidism, MBX 2109, was granted orphan drug status. MBX 2109, which is administered by injection subcutaneously, is currently being evaluated in an early-stage trial to test its safety, tolerability, pharmacodynamics and pharmacokinetics.
Full Story: eMPR (7/26) 
 
A Carmel-based biopharmaceutical company has received an Orphan Drug designation from the U.S. Food and Drug Administration for its lead therapeutic product candidate. The drug, MBX 2109, is being developed for the treatment of hypoparathyroidism. More (Source: IBJ may require subscription)
IHIF's Policy Corner
What We're Following at Home and on the Hill

IHIF Actions:
  • Participated in direct outreach to Indiana legislators opposing drug pricing provisions in the reconciliation package
  • Continued support for rapid reauthorization of the SBIR/STTR programs. To view IHIF's final letter, please click here.
  • Watching: Summer Study Committees
The Indiana Health Industry Forum provides guidance and leadership on public policy issues that contribute to innovation in the health science sector, deliver therapies to patients in need, and further the development and growth of our member companies. IHIF works at the federal and state level and partners with several other organizations and groups to support specific initiatives and legislation.
Final reconciliation package a "disservice to patients and researchers"
August 7, 2022
BIO's Statement on the Drug Pricing Provisions in the Inflation Reduction Act
Senate lawmakers today passed a sweeping, $740 billion reconciliation package after an all-night session. Following the vote, Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), made the following statement:
"Nothing we heard from the lengthy floor debate on the Senate floor over the past two days can take away from the fact that every credible analysis of the Inflation Reduction Act comes to the same conclusion: fewer cures for patients. For that reason, we remain in staunch opposition to the government price control schemes included in the final reconciliation package passed today. 

Read Full Statement (Source: BIO)
The signing of the Inflation Reduction Act into law that grants Medicare the ability to "negotiate" drug prices aims to lower health care costs for Americans; however, from the point of view of those in the pharma and biotech industries, this would not be the case. The new law "would drastically slow critical investments in future research and development, stalling drug innovation, and ensuring the next generation of groundbreaking therapies remains out of reach for American patients," said BIO President and CEO Dr. Michelle McMurry-Heath.
Full Story: Health (8/19)  
Eli Lilly and Co., one of the largest and oldest companies in Indiana, announced Saturday it will look outside the state for corporate expansion projects in the wake of a sweeping abortion ban passed by the Legislature and signed by Gov. Eric Holcomb on Friday. The Indianapolis-based drugmaker said the abortion law could hinder its ability to attract diverse scientific, engineering and business talent to Indiana. Columbus-based Cummins Inc., another of the state’s biggest employers, echoed Lilly’s concerns about talent recruitment and retention in a media release on Saturday and said, “As we continue to grow our footprint with a focus on selecting communities that align with our values and business goals, this law will be considered in our decision-making process.” A Lilly spokeswoman said the company still plans to honor its current commitments in Indiana. In May, it announced plans  to spend $2.1 billion to open two manufacturing sites in Boone County. IBJ’s John Russell has more.
Indiana needs to spend an additional $242 million a year to help improve the state’s strained and fragmented public health system, a blue-ribbon commission recommended Thursday. The state ranks among the worst in the nation for obesity, smoking, infant mortality and other critical measures, and the life expectancy of Hoosiers has declined in recent years after peaking in 2010, the commission said. More
Special Offers for IHIF Members
Lab-Crafters showcases our I-FLEX System, showing you all it can do. It truly allows for quick change as your lab requirements change.

This animated video will take you through all the features of an individual bench. 

Please reach out to Betsy Fouts with any questions, suggestions, or comments. 
OpenTrons – Laboratory Automation Solutions
Promotional Offer for IHIF Members: FREE pipette with OT-2 robot order!
Introducing the OT-2, your personal pipetting robot.
Upcoming Events
  • On September 8, Biocom California is co-hosting a webinar: “Best practices shared to help biotech/medtech startups navigate USPTO and FDA procedures.” Register here.  This event is in collaboration with the U.S. Patent and Trademark Office (USPTO), U.S. Food and Drug Administration (FDA) and Biocom California.
  • NCI’s SBIR office will host an informational webinar on Wednesday, August 24th, at 1:00pm ET to discuss their 2023 SBIR contract solicitation topics. NCI SBIR contract specialists will cover program information including solicitation basics, detailed topic explanations, project requirements, proposal tips and conclude with a Q&A session with the audience. Register here.
  • Following their June 23 webinar on Navigating the Military Medical Conference, DoD & Funding Opportunities, G2G Consulting will host a webinar to help attendees prepare to maximize participation in MHSRS in September. They will share details on the agenda and breakout sessions, targeting, relationship development and more —to ensure attendees are prepared to maximize participation in the largest annual military medical conference. Register here.
The MedTech Conference
Boston, MA - October 24-26, 2022

The MedTech Conference is poised to make its momentous return in Boston, MA from October 24-26, 2022! After two years of virtual conferences, come gather with more than 3,000 of the world's top medtech executives for three days of networking, education and inspiration. Featuring more than 100 sessions led by dynamic speakers, over 150 exhibitors from around the world, and the newly launched Investor Forum, this year's Conference is a can't-miss event. Visit our website to learn more and register: https://themedtechconference.com/

IHIF Members take 10% off your registration using promo code SPO22
Nordic Life Science Days - September 28-29, 2022 Malmo, Sweden
Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world of life science, and created a unique place to do business. Most attendees express their delight in the informal atmosphere, combined with an organised approach to meeting highly relevant people. Return visitors come back because they feel they belong to our growing community.

Indiana companies and IHIF Members have been invited to participate in this event.

BioCom Global Life Science Partnering Conference - Save the Date
FEBRUARY 28TH TO MARCH 2ND, 2023
THE LODGE AT TORREY PINES | SAN DIEGO, CA
This conference is an exclusive global partnering forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies. Join us next February 2023, where industry leaders will debate current trends, companies will showcase their latest technologies and all attendees will have the opportunity to schedule one-on-one meetings with leading deal-makers from around the globe.

The partnering conference and the relationships you build promise to be fruitful for your business ventures this year and for many years to come. We are excited by the prospect of continuing an annual bio-pharma partnering conference that brings together leading deal makers and emerging biotechs from around the world.

Eiteljorg Museum Plans Scottish Exhibition
One of the interesting conversations that came out of the SLA visit in May was a connection to an upcoming exhibition at the Eiteljorg Museum of Native American Art in Indianapolis. In August 2023, the museum will feature the works of Alfred Jacob Miller - a Scottish landscape artist who sketched and painted scenes of the American West on behalf of his patron, Sir William Drummond Stewart. Originally displayed in Murthly Castle in Perthshire, Scotland, the collection has been reassembled and will be displayed as it would have appeared to Sir Stewart. The paintings show details of the Rendezvous - an important trading event for Native Americans, trappers, traders, and inhabitants of the American West in the 1800s. For more information on the exhibit or if you might have an interest in becoming a corporate sponsor, please learn more. IHIF and SLA are excited to help support this fascinating cultural connection! Learn More: Alfred Jacob Miller: Revisiting the Rendezvous in Scotland and Today
BioFutures 2022 Available Now!


Many thanks to our partners at the Indianapolis Business Journal for another great edition!

Highlights include:
  • The Business of Bone Health: Innovative entrepreneurs are strengthening the "Orthopedic Capital of the World"
  • Laboratory Essentials: Many of the tools researchers use are born or made in Indiana
  • COVID Crusaders: Indiana manufacturers and innovators continue to play key roles in the pandemic fight
BIO Business Solutions - Special Discounts for IHIF Members
BIO Business Solutions provides cost-savings offers to eligible IHIF Members. To learn more about the programs and services available, please click here. Not an IHIF member? Join today!
Featured Program
Please share with someone in your company who would find this helpful
About ADP
ADP provides life sciences organizations of all sizes the opportunity to outsource their day-to-day administrative tasks across human resources, compliance, payroll, benefits, talent management, employee support, and more.

As the nation’s largest Certified Professional Employer Organization (PEO), ADP streamlines the HR process, takes work off your plate, and frees up time for you to focus on strategic goals to grow your business. For small and midsized businesses, a PEO can save money on hiring additional HR personnel. Lean on the strategic relationship of an experienced HR partner like ADP.
IHIF Member Benefits

Up to 25% discount on services, waived implementation fees, and more on the following services:
  • ADP TotalSource, ADP’s Professional Employer Organization (PEO) solution, for small to mid-size organizations who don’t want HR to get in the way of revenue-generating activities.
  • Limited Time Promotion: ADP will waive the administrative fee for the first 3 months to member companies with 10+ employees that enter a PEO evaluation.
  • RUN Powered by ADP® payroll and HR platform designed for small businesses with less than 50 employees.
  • ADP Workforce Now®, the technology platform for companies with over 50 employees, includes HR, payroll, benefits administration, talent management, and compliance functionality. 
  • Note: Member company must be a new ADP customer or a new user of specified services to utilize these benefits
Join IHIF - Become a Member Today!
About IHIF Membership

Now is a great time to become a member of the Indiana Health Industry Forum! Join your voice to over 150 current member companies to impact the strategic direction of Indiana's health science sector.

Membership in IHIF offers a number of solutions:
  • Promote your business, locally, nationally, and globally.
  • Support the industry in the state and contribute directly to its growth and direction.
  • Find others who share your interests and build your business network.
  • Lend your voice to public policies that support innovation.
  • Directly impact your bottom line with significant savings and discount programs exclusively for IHIF members.

To complete a membership application, click here. 
Time to renew? Try it on-line! It's quick and easy! IHIF members can renew their memberships on-line at any time and update information in the Member Directory. Not an IHIF Member? Apply on-line or download an application packet now!